By the METAvivor Advocacy Team As the legislative gears of Washington, D.C., grind back into motion following...
Nana Muazin
In the heart of Alabama’s burgeoning biotech corridor, a quiet revolution is taking place—not just in laboratories,...
For decades, the standard approach to treating aggressive cancers has been defined by the "more is better"...
Memphis, TN – A groundbreaking study from St. Jude Children’s Research Hospital has fundamentally shifted our understanding...
By Shelley Loving, CNE, CPC, INHC The fundamental premise of long-term health is deceptively simple: real food...
In the heart of the American South, the humble peanut—long a staple of agriculture and nutrition—is undergoing...
In a significant boost for the biotech sector, LifeMine Therapeutics, the Cambridge-based firm spearheaded by veteran entrepreneur...
In a landmark achievement for reproductive medicine and genetic science, researchers at Newcastle University and The Newcastle...
A pivotal Phase III trial combining Gilead Sciences’ Trodelvy (sacituzumab govitecan) with Merck & Co.’s Keytruda (pembrolizumab)...
In a landmark decision that promises to reshape the treatment landscape for the most common subtype of...
